|
|
|
Volumn 41, Issue 6, 2006, Pages 408-412
|
|
Disfigurement of p16INK4A gene expression in development of ovarian cancer and the mechanism
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 AZA 2' DEOXYCYTIDINE;
ANTINEOPLASTIC ANTIMETABOLITE;
AZACITIDINE;
CYCLIN DEPENDENT KINASE INHIBITOR 2A;
DRUG DERIVATIVE;
MESSENGER RNA;
ANIMAL;
ARTICLE;
BIOSYNTHESIS;
CELL PROLIFERATION;
DNA METHYLATION;
DRUG EFFECT;
DRUG SCREENING;
FEMALE;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
IATROGENIC DISEASE;
MOUSE;
NUDE MOUSE;
OVARY TUMOR;
PATHOLOGY;
PROMOTER REGION;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
TIME;
TUMOR CELL LINE;
TUMOR VOLUME;
WESTERN BLOTTING;
ANIMALS;
ANTIMETABOLITES, ANTINEOPLASTIC;
AZACITIDINE;
BLOTTING, WESTERN;
CELL LINE, TUMOR;
CELL PROLIFERATION;
CYCLIN-DEPENDENT KINASE INHIBITOR P16;
DNA METHYLATION;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
MICE;
MICE, NUDE;
NEOPLASM SEEDING;
OVARIAN NEOPLASMS;
PROMOTER REGIONS (GENETICS);
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
RNA, MESSENGER;
TIME FACTORS;
TUMOR BURDEN;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
|
EID: 39049114731
PISSN: 0529567X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
